A year ago, vaccine drives against COVID-19 were just beginning. Now, more than 4.4 billion people have had one or more dose β about 56% of the world population. The vaccination of so many in such a short space of time, so soon after the unparalleled rapid development of the vaccines, has saved huge numbers of lives and is a triumph for science and research.
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 52 print issues and online access
$199.00 per year
only $3.83 per issue
Prices may be subject to local taxes which are calculated during checkout
Nature 600, 580-583 (2021)
doi: https://doi.org/10.1038/d41586-021-03686-x
References
MeslΓ©, M. M. I. et al. Euro Surveill. 26, pii=2101021 (2021).
Chen, Z. et al. Preprint at https://doi.org/10.1101/2021.10.25.21265504 (2021).
Barry, V. et al. Morb. Mortal. Wkly Rep. 70, 818β824 (2021).
Wrigley-Field, E. et al. Preprint at https://doi.org/10.1101/2021.11.19.21266612 (2021).
Related Articles
-
π Image
Omicron likely to weaken COVID vaccine protection -
π Image
Six months of COVID vaccines: what 1.7 billion doses have taught scientists -
π Image
How protein-based COVID vaccines could change the pandemic
Subjects
Latest on:
-
π Image
What it will take to stop the spiralling Ebola outbreak
News Explainer
-
π Image
Ebola outbreak is a global health emergency: what happens next
News
-
π Image
The fightback against antimicrobial resistance starts at home
Outlook
-
Towards Conversational AI for Disease Management
Article
-
π Image
Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource
Article
-
π Image
Lethal plague outbreaks in Lake Baikal hunter-gatherers 5,500 years ago
Article
-
π Image
Why are so many young people getting cancer? What researchers do and donβt know
News
-
π Image
What it will take to stop the spiralling Ebola outbreak
News Explainer
-
π Image
Global lung cancer burden shifting to middle-income countries
Outlook
Jobs
-
Associate or Senior Editor (Nature Geoscience β Biogeochemistry)
Job Title: Associate or Senior Editor (Nature Geoscience - Biogeochemistry) Organisation: Nature Portfolio Location: Shanghai, Beijing, Milan and P...
Shanghai, Beijing, Milan and Pune
Springer Nature Ltd
-
Associate or Senior Editor (Nature Geoscience - Solid Earth)
Job Title: Associate or Senior Editor (Nature Geoscience - Solid Earth) Organisation: Nature Portfolio Location: Shanghai, Beijing, Milan and Pune ...
Shanghai, Beijing, Milan and Pune
Springer Nature Ltd
-
Associate or Senior Editor, Nature Reviews Physics
Job Title: Associate or Senior Editor, Nature Reviews Physics Location: Shanghai, Beijing or Madrid β Hybrid working model Applications Deadline: 8...
Shanghai, Beijing or Madrid β Hybrid working model
Springer Nature Ltd
-
Postdoctoral Research Fellow in Semiconductor Devices at NIMS
NIMS invites applications for a Postdoctoral Research Fellow in Semiconductor Devices (approx. 4M-6M JPY per annum, at Tsukuba, Japan).
Tsukuba, Japan (JP)
National Institute for Materials Science (NIMS)
-
Permanent Researcher in Next-Generation Semiconductor Devices at NIMS
NIMS invites applications for a Permanent Researcher in Next-Generation Semiconductor Devices (approx. 6M-10M JPY per annum, at Tsukuba, Japan).
Tsukuba, Japan (JP)
National Institute for Materials Science (NIMS)
